The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Boston Biomedical; Celgene; Novartis
Consulting or Advisory Role - Boston Biomedical; Novartis
Research Funding - Bristol-Myers Squibb; Delta-Fly Pharma; Five Prime Therapeutics; Genentech; Merck; Roche/Genentech; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Boston Biomedical; Delta-Fly Pharma; Novartis

A randomized, open-label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T-DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2-positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC).
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Manish A. Shah
Consulting or Advisory Role - Lilly
Research Funding - Genentech (Inst); Sanofi (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Honoraria - Bayer Yakuhin
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Jaffer A. Ajani
No Relationships to Disclose
 
Tina van der Horst
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Marie-Laurence Harle-Yge
Employment - Proacta
 
Yongzhe Piao
Employment - Roche/Genentech
 
Betsy Althaus
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Lilly; Nordic Group; Roche/Genentech
Research Funding - Novartis